Michael Anthony Brito, PhD
2.2K posts

Michael Anthony Brito, PhD
@MBritoNeuro
Neuroscientist. Bassist. @UCSBpsych @NGPMichigan @UCSF alum. From academic research in consciousness/psychedelics to building the future of BCIs @neuralink.


Let me say this clearly: LLMs cannot feel emotions. Emotions are evolutionary mechanisms. They push us to avoid danger or approach what is beneficial. We experience emotions because we are alive, and we want to stay alive. LLMs are not alive. Yes, emotional language may be encoded somewhere in the LLM. Yes, it may even be associated with some LLM output. But that is just a superficial property. There is nothing deeper behind it. For a very simple reason: LLMs do not have an intrinsic and inescapable drive to stay alive. This is what we call “motivation fault line” in our paper describing seven fault lines between human and artificial intelligence. * Paper in the first reply

Molecular self-assembly. Private AI. Brain-computer interfaces. AGI safety. Hacking aging biology. Dyson spheres. Funding models for long-horizon science. We can’t wait for the talks at our upcoming Vision Weekend. June 5-7 in London. Full speaker lineup: • Greg Wayne (Google DeepMind) on universal AI assistants • William Shih (Harvard University) on self-assembly and the coming age of molecular machines • @moxie (Confer) on private AI • @leecronin (University of Glasgow) • @irinarish (Mila) on beyond scaling: toward continual and adaptive intelligence • @eboyden3 (MIT) on incentives in science • @anderssandberg (Institute for Future Studies) on Dyson 2070: how fast can we build a Dyson sphere and how stable are they? • João Pedro de Magalhães @jpsenescence (University of Birmingham) on hacking aging biology • @dorothychou (Google DeepMind) on capital for the long game: financing durable innovation in an age of hype • @SergeyStavisky (UC Davis) on high-bandwidth BCIs for motor and communication recovery in people with paralysis • Žiga Avsec @Avsecz (Google DeepMind) on advancing regulatory variant effect prediction with AlphaGenome • Christopher Rozell @crozSciTech (Georgia Tech) on closed-loop neuroengineering • @JerzySzablowski (Rice University) on precision neuromodulation through molecular engineering and focused ultrasound • Christine Peterson @lifeext (Foresight Institute) on Foresight, 40 years later • @MariusHobbhahn (Apollo Research) on the case for AGI safety products • @WeinbaumJonah (Institute for Progress) on the 'launch sequence': towards a concrete agenda for defensive acceleration • Peter Gehle (Tübingen AI Institute) • @joemeyerowitz (Field Foundry) • @jncstrd (SPRIND) on challenges as a tool for breakthrough innovation • @RonitKanwar (Renaissance Philanthropy) on fuelling scientific renaissances • Lynne Cox @OxAgeN_oxford (University of Oxford) • Adam Shai @adamimos on the neural basis of intelligent behavior • Zoë Brammer (Google DeepMind) on AI for science 2030 • Darja Isaksson (Vinnova) • Thane Campbell @Thane_ac (Deep Science Ventures) • Ankur Vora (Google DeepMind) on AI for science 2030 • Leah Morris @leahelizmorris on AI for science • @KirillEves (e184) • Kathleen Fisher (ARIA) • Mehmet Fisek (Meridial) • @JacquesCarolan (ARIA) moderator • Barbara Diehl @barbaradiehl13 (SPRIND) moderator • Eric Gilliam @eric_is_weird (Renaissance Philanthropy) moderator • @allisondman (Foresight Institute) moderator Powered by: @apolloaievals @ARIA_research @e184media @CUHPartners @RenPhilanthropy @SPRIND :










ALS has gradually taken away Kenneth’s ability to speak. Through Neuralink’s VOICE clinical trial, he’s exploring how a brain-computer interface designed to translate thought to speech could help restore autonomy in his daily life. Watch to learn more:












